At close: December 20 at 4:00:03 PM EST
After hours: December 20 at 4:09:38 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-10,120.14
-11,188.81
-7,239.35
-3,903.27
Investing Cash Flow
-218.19
-543.19
-525.00
-136.80
Financing Cash Flow
30,509.43
38,425.06
9,357.88
-340.58
End Cash Position
31,057.40
32,626.77
5,933.70
4,340.18
Capital Expenditure
--
--
--
-136.80
Issuance of Capital Stock
29,028.47
38,335.12
--
--
Issuance of Debt
--
--
10,468.97
--
Free Cash Flow
-9,795.14
-11,188.81
-7,239.35
-4,040.07
12/31/2021 - 12/29/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GANX Gain Therapeutics, Inc.
1.5600
-0.64%
INMB INmune Bio, Inc.
4.4000
-0.45%
ZIVOW Zivo Bioscience, Inc.
1.3000
+4.00%
ACTU Actuate Therapeutics, Inc. Common stock
6.77
-3.97%
KALV KalVista Pharmaceuticals, Inc.
8.36
+3.34%
ACOG Alpha Cognition Inc. Common Stock
4.9300
-0.60%
ETNB 89bio, Inc.
7.94
+12.94%
CALC CalciMedica, Inc.
2.7600
-0.36%
NKTX Nkarta, Inc.
2.3700
+7.73%
EPIX ESSA Pharma Inc.
1.6000
0.00%